KDHE Home - Laboratories - Neonatal Chemistry
| Neonatal Chemistry |
|||||||
Kansas Neonatal Chemistry ScreeningIntroduction
The Kansas Health and Environmental Laboratories began testing for phenylketonuria (PKU) in 1965 when screening for neonatal PKU was mandated in Kansas. Over the next thirty years the law was amended and the Neonatal Chemistry Laboratory added screening for congenital hypothyroidism (1977), galactosemia (1984), and hemoglobinopathies (1990). July 1, 2008 the Neonatal Chemistry Laboratory of the Kansas Department of Health and Environment began the recommended expanded screening panel with the addition of screening for cystic fibrosis, biotinidase and congenital adrenal hyperplasia. Additional screening for amino acid, fatty acid, and organic acid disorders were added on October 20, 2008 completing the expansion of the neonatal chemistry screening panel and increasing the number of disorders screened from 4 to a total of 29 as recommended by the national American College of Medical Genetics. In Kansas, neonatal screening responsibilities are shared between the Neonatal A general explanation of the Kansas Newborn Screen is found in our brochures. For more information about our brochures designed for expectant or new mothers, please go to Kansas Newborn Screening Brochure. If your facility would like a packet of brochures please fax your request to the Neonatal Chemistry Screening Program at (785) 296-0978. If you, as an expectant or new mother would like a brochure, please contact your obstetrician or general health care provider.
|